Al-Munther Sultan

Managing Director
Focuses on healthcare and life sciences M&A 
15+ years of experience advising founder-owners, private equity and corporates 
Expert in business exits, fund raising/partial company exits and buy-side support
London
@alvarezmarsal
LinkedIn
Copied!
Al-Munther Sultan is a Managing Director of Healthcare and Life Sciences with Alvarez & Marsal in London.

Mr. Sultan has spent over 15 years advising founder-owners, private equity and corporates on a range of M&A services, including business exits, fund raising/partial company exits and acquisition support. He has led notable transactions, most recently the sale of private equity backed Vanguard Healthcare Solutions to iCON Infrastructure and the sale of Aesthetic Technology to Omni Partners. 

Prior to joining A&M, Mr. Sultan was Director, Healthcare & Life sciences M&A with KPMG, where he held a senior position in its M&A practice for the past six years. Prior to this he worked in other M&A advisory firms and in leveraged finance for an international bank. 

Mr. Sultan earned a bachelor’s degree in accounting and finance from Liverpool University.

Insights By This Professional

The medical consumables sector is a vital component of healthcare, underpinning diagnostics, treatment, and infection prevention. With a global market projected to grow from $422 billion in 2025 to $571 billion by 2035, at a CAGR of 3.2%, the sector is poised for steady expansion.
The social care sector is a cornerstone of society, contributing £50 billion annually to the UK economy. It plays a vital role in supporting the well-being and diverse needs of our population. However, it now stands at a critical juncture.
Rising cost pressures, stricter regulatory demands and advancements in emerging therapeutics are intensifying competition within the industry. These dynamics are fuelling the demand for greater efficiency in development lifecycles, creating significant opportunities for outsourced providers like Contract Research Organisations (CROs).
The Consumer Health market, currently valued at over $357 billion globally, is projected to almost double by 2034. Through 2025 and onwards, the Consumer Health market is poised for steady growth. The currently fragmented sector offers potential for roll-up opportunities, driven by widespread demand for an integrated offering.
Latest insights The latest insights from Al-Munther Sultan's team
Thought Leadership
The medical consumables sector is a vital component of healthcare, underpinning diagnostics, treatment, and infection prevention. With a global market projected to grow from $422 billion in 2025 to $571 billion by 2035, at a CAGR of 3.2%, the sector is poised for steady expansion.
Contact me
FOLLOW & CONNECT WITH A&M